Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine
November 23, 2020
Pfizer Develops a Vaccine...Implications for Tailwinds
November 10, 2020
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients
November 9, 2020
November 7, 2020
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies
November 2, 2020
Sell Mortimer, Sell!!!
October 31, 2020
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines
October 27, 2020
Time for Small Cap to Shine?
October 24, 2020
TFF Firing on All Cylinders; An Update on TAC and CBD
October 21, 2020
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation Powder
October 20, 2020
Transcript of Processa Pharmaceuticals Business Update
November 12, 2020
David Young – Chief Executive Officer
Jim Stanker – Chief Financial Officer
Sian Bigora – Chief Development Officer
AUSTIN, Texas--(BUSINESS WIRE)--Nov. 5, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...
All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.
For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $250 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.